, Volume 70, Issue 3, pp 1009–1021 | Cite as

Biological characterization and pluripotent identification of ovine amniotic fluid stem cells

  • Wenhua Pei
  • Tengfei Lu
  • Kunfu Wang
  • Meng Ji
  • Shuang Zhang
  • Fenghao Chen
  • Lu Li
  • Xiangchen Li
  • Weijun Guan
Original Article


Mesenchymal stem cells derived from amniotic fluid have become one of the most potential stem cell source for cell-based therapy for the reason they can be harvested at low cost and without ethical problems. Here, we obtained amniotic fluid stem cells (AFSCs) from ovine amniotic fluid and studied the expansion capacity, cell markers expression, karyotype, and multilineage differentiation ability. In our work, AFSCs were subcultured to passage 62. The cell markers, CD29, CD44, CD73 and OCT4 which analyzed by RT-PCR were positive; CD44, CD73, CD90, CD105, NANOG, OCT4 analyzed by immunofluorescence and flow cytometry were also positive. The growth curves of different passages were all typically sigmoidal. The different passages cells took on a normal karyotype. In addition, AFSCs were successfully induced to differentiate into adipocytes, osteoblasts and chondrocytes. The results suggested that the AFSCs isolated from ovine maintained normal biological characteristics and their multilineage differentiation potential provides many potential applications in cell-based therapies and tissue engineering.


Ovine Amniotic fluid Stem cell Differentiation 



This research was supported by the Project supported by the National Natural Science Foundation of China (Grant Nos. 31472099, 31672404).

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interests regarding the publication of this paper.


  1. Alsalameh S et al (2004) Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 50:1522–1532CrossRefGoogle Scholar
  2. Antonucci I et al (2011) Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant 20:789–795CrossRefGoogle Scholar
  3. Antonucci I et al (2012) Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des 18:1846–1863CrossRefGoogle Scholar
  4. Bobis S, Jarocha D, Majka M (2006) Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 44:215–230Google Scholar
  5. Bollini S et al (2011) Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 20:1985–1994CrossRefGoogle Scholar
  6. Cananzi M, De Coppi P (2012) CD117(+) amniotic fluid stem cells State of the art and future perspectives. Organogenesis 8:77–88CrossRefGoogle Scholar
  7. Cananzi M, Atala A, De Coppi P (2009) Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 18:17–27CrossRefGoogle Scholar
  8. Colosimo A et al (2013) Prolonged in vitro expansion partially affects phenotypic features and osteogenic potential of ovine amniotic fluid-derived mesenchymal stromal cells. Cytotherapy 15:930–950CrossRefGoogle Scholar
  9. Da Sacco S et al (2010) Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 183:1193–1200CrossRefGoogle Scholar
  10. Da Sacco S, De Filippo RE, Perin L (2011) Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration. Curr Opin Organ Transplant 16:101–105CrossRefGoogle Scholar
  11. De Coppi P et al (2007a) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100–106CrossRefGoogle Scholar
  12. Delo DM et al (2006) Amniotic fluid and placental stem cells. Methods Enzymol 19:426–438CrossRefGoogle Scholar
  13. De Coppi P et al (2007b) Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177:369–376CrossRefGoogle Scholar
  14. Di Tomo P et al (2013) Calcium sensing receptor expression in ovine amniotic fluid mesenchymal stem cells and the potential role of R-568 during osteogenic differentiation. PLoS ONE 8:e73816CrossRefGoogle Scholar
  15. Di Trapani M et al (2015) Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age. Stem Cells Dev 24:132–143CrossRefGoogle Scholar
  16. Galende E et al (2010) Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram 12:117–125CrossRefGoogle Scholar
  17. Gao Y et al (2014) Amniotic fluid-derived stem cells demonstrated cardiogenic potential in indirect co-culture with human cardiac cells. Ann Biomed Eng 42:2490–2500CrossRefGoogle Scholar
  18. Ghafarzadeh M, Eatemadi A, Fakhravar Z (2016) Human amniotic fluid derived mesenchymal stem cells cause an anti-cancer effect on breast cancer cell line in vitro. Cell Mol Biol (Noisy-le-grand) 62:102–106Google Scholar
  19. In ‘tAnker PS et al (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548–1549CrossRefGoogle Scholar
  20. Joo S et al (2012) Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res 35:271–280CrossRefGoogle Scholar
  21. Kang NH et al (2012) Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells. Cancer Gene Ther 19:517–522CrossRefGoogle Scholar
  22. Kaviani A et al (2001) The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36:1662–1665CrossRefGoogle Scholar
  23. Kim J et al (2007) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 40:75–90CrossRefGoogle Scholar
  24. Kim EY, Lee KB, Kim MK (2014) The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy. BMB Rep 47:135–140CrossRefGoogle Scholar
  25. Mauro A et al (2010) Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells. Vet Res Commun 34:S25–S28CrossRefGoogle Scholar
  26. Miki T, Strom SC (2006) Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev 2:133–141CrossRefGoogle Scholar
  27. Pappa KI, Anagnou NP (2009) Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 4:423–433CrossRefGoogle Scholar
  28. Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annual Rev Biomed Eng 12:87–117CrossRefGoogle Scholar
  29. Peister A et al (2009) Amniotic fluid stem cells produce robust mineral deposits on biodegradable Scaffolds. Tissue Eng Part A 15:3129–3138CrossRefGoogle Scholar
  30. Phermthai T et al (2010) A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol 11:79CrossRefGoogle Scholar
  31. Priest et al (1984) Metabolism of [4-14C] androstenedione by cells cultured from human amniotic fluid. J Steroid Biochem 20:935–939CrossRefGoogle Scholar
  32. Prusa AR et al (2003) Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18:1489–1493CrossRefGoogle Scholar
  33. Rennie K et al (2012) Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int 2012:721538CrossRefGoogle Scholar
  34. Rota C et al (2012) Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 21:1911–1923CrossRefGoogle Scholar
  35. Roubelakis MG et al (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16:931–951CrossRefGoogle Scholar
  36. Skardal A et al (2012) Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med 1:792–802CrossRefGoogle Scholar
  37. Tsai MS et al (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19:1450–1456CrossRefGoogle Scholar
  38. Wang Y et al (2016) The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits. Mol Med Rep 14:234–242CrossRefGoogle Scholar
  39. Young BK et al (2016) Amniotic fluid as a source of multipotent cells for clinical use. J Perinat Med 44:333–337CrossRefGoogle Scholar
  40. Zavatti M et al (2015) Critical-size bone defect repair using amniotic fluid stem cell/collagen constructs: effect of oral ferutinin treatment in rats. Life Sci 121:174–183CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2018

Authors and Affiliations

  • Wenhua Pei
    • 1
  • Tengfei Lu
    • 1
  • Kunfu Wang
    • 2
  • Meng Ji
    • 1
  • Shuang Zhang
    • 3
  • Fenghao Chen
    • 4
  • Lu Li
    • 5
  • Xiangchen Li
    • 1
  • Weijun Guan
    • 1
  1. 1.Institute of Animal ScienceChinese Academy of Agricultural SciencesBeijingChina
  2. 2.College of Wildlife ResourcesNortheast Forestry UniversityHarbinChina
  3. 3.Research Center for Sports Scientific ExperimentHarbin Sport UniversityHarbinPeople’s Republic of China
  4. 4.College of Human Movement ScienceHarbin Sport UniversityHarbinChina
  5. 5.College of Animal Science and TechnologyAgricultural University of HebeiBaodingChina

Personalised recommendations